Moreover, PNPLA3 148M allele carriers with HCV infection have been reported to have increased prevalence of steatosis, fibrosis, cirrhosis and hepatocellular carcinoma [18-21]. This evidence concerns the gene PNPLA3 and Cirrhosis.